ArticleAIDS research and therapy2026
Prevalence and determinants of anemia among people living with HIV receiving antiretroviral therapy in public health facilities in Jigjiga, Ethiopia.
Article in AIDS research and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnemia is a significant concern for people with HIV worldwide, as it is associated with reduced life expectancy, fatigue, weakness, reduced physical functioning, psychological distress such as depression and anxiety, and poorer quality of life. This study aimed to assess the prevalence of anemia and identify factors associated with anemia among people with HIV receiving antiretroviral therapy at public health institutions in Jigjiga, Ethiopia. METHODS AND MATERIALS: An institution-based cross-sectional study was conducted from July 11 to August 12, 2023, involving 392 people with HIV receiving antiretroviral therapy in Jigjiga, Ethiopia. Data were collected using a structured questionnaire and hemoglobin measurements, then coded and entered in EpiData version 3.1. Statistical analysis was performed using SPSS version 20, with multivariate logistic regression used to identify factors associated with anemia. Statistical significance was set at p < 0.05.
resultsThe overall prevalence of anemia in the study population was 39% (95% CI: 34.3-44.2). Among those with anemia, 0.6% had severe anemia, 33.5% had moderate anemia, and 4.9% had mild anemia. Female sex, presence of opportunistic infections, and low dietary diversity scores were significantly linked to anemia in multivariate analysis (p < 0.05).
conclusionAnemia was identified as a moderate public health problem among people with HIV receiving ART at the study sites. The findings highlight the importance of providing targeted support to women and ensuring timely diagnosis and treatment of opportunistic infections to reduce the severity and impact of anemia. Furthermore, patients with poor dietary diversity should be offered nutritional counselling to enhance their health outcomes. SIGNIFICANCE FOR PUBLIC HEALTH: Anemia continues to pose a substantial public health burden among people living with HIV/AIDS, particularly in low-resource settings. This study provides context-specific evidence from Jigjiga, a region with limited existing data, helping to fill a critical knowledge gap. The results offer valuable insights for healthcare providers and policymakers to design targeted interventions, improve anemia screening and management, and enhance the quality of life for People with HIV on ART.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.